Suchergebnisse - "Xu, Guangxue"

PubPharm (25)

1

APOE loss-of-function variants : Compatible with longevity and associated with resistance to Alzheimer's disease pathology

enthalten in: Neuron | 2024

von Chemparathy, A. | Le Guen, Y. | Chen, S. | +25

UpdateOf: medRxiv. 2023 Jul 24;:. - PMID 37547016

2

Structural basis of the recognition of adeno-associated virus by the neurological system-related receptor carbonic anhydrase IV

enthalten in: PLoS pathogens | 2024

von Zhang, R. | Liu, Y. | Yu, F. | +4

3

Long sequence insertion via CRISPR/Cas gene-editing with transposase, recombinase, and integrase

enthalten in: Current opinion in biomedical engineering | 2023

von Wang, X. | Xu, G. | Johnson, W. | +5

4

APOEloss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s Disease pathology

enthalten in: bioRxiv.org | 2023

von Chemparathy, A. | Guen, Y. | Chen, S. | +20

5

APOE loss-of-function variants : Compatible with longevity and associated with resistance to Alzheimer's Disease pathology

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Chemparathy, A. | Guen, Y. | Chen, S. | +20

UpdateIn: Neuron. 2024 Jan 29;:. - PMID 38301647

6

Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults : Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi

enthalten in: Vaccines | 2023

von Al Kaabi, N. | Yang, Y. | Eldin Hussein, S. | +19

7

Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors

enthalten in: bioRxiv.org | 2022

von Xu, G. | Zhang, R. | Li, H. | +3

8

Structural basis for the neurotropic AAV9 and the engineered AAVPHP.eB recognition with cellular receptors

enthalten in: Molecular therapy. Methods & clinical development | 2022

von Xu, G. | Zhang, R. | Li, H. | +3

9

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants

enthalten in: Vaccines | 2022

von Zhang, Y. | Tan, W. | Lou, Z. | +27

10

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35